首页> 外文期刊>Journal of Human Reproductive Sciences >Window of Implantation is Significantly Displaced in Patients with Adenomyosis with Previous Implantation Failure as Determined by Endometrial Receptivity Assay
【24h】

Window of Implantation is Significantly Displaced in Patients with Adenomyosis with Previous Implantation Failure as Determined by Endometrial Receptivity Assay

机译:子宫内膜容受性测定确定先前有植入失败的子宫腺肌症患者的植入窗口明显移位

获取原文

摘要

Background: Adenomyosis is associated with implantation failure and poor reproductive performance in IVF/ICSI cycles. Aims: To compare if window of implantation (WOI) is displaced in patients having adenomyosis compared to controls using endometrial receptivity array (ERA) test. Settings and Design: Retrospective Case control study. 374 patients with previous one or more IVF failures who underwent ERA test between 2013-2016 at our centre were enrolled. Patients were divided into two groups; Group A-36 patients with adenomyosis (study group) and Group B- 338 patients without adenomyosis (controls). Statistical Analysis: Normality assumptions for continuous variables were tested using Kolmogorov Smirnov test. Mean values of two groups were compared using Student's t-independent test. Frequency data by categories were compared using Chi-square/Fisher's exact test. Risk ratio and 95% confidence limits were calculated. P 0.05 was considered for statistical significance. Results: WOI was displaced (Non Receptive ERA) significantly in adenomyosis 47.2% (17/36) compared to controls 21.6% (73/338) ( P 0.001, CI-8.7%-42.5%) making risk ratio of displaced WOI in adenomyosis versus controls to be 2:1. The incidence of RIF was 66.6% in adenomyosis compared to 34.9% in controls ( P 0.001, CI- 15.5%-47.9%). Pregnancy rate after personalized embryo transfer in adenomyosis group was 62.5%, signifying displaced WOI as a cause of implantation failure in adenomyosis patients with previous implantation failure. Conclusions: Our study suggests it is prudent to evaluate Endometrial receptivity before embryo transfer in patients with adenomyosis to avoid wastage of good embryos.
机译:背景:子宫腺肌病与IVF / ICSI周期的植入失败和生殖能力差有关。目的:比较子宫内膜异位症患者与子宫内膜接受阵列(ERA)测试相比,植入窗口(WOI)是否移位。设置和设计:回顾性病例对照研究。入选了2013年至2016年间接受ERA测试的374例先前一次或多次IVF失败的患者。患者分为两组。 A-36组有子宫腺肌病的患者(研究组)和B-338组没有子宫腺肌病的患者(对照组)。统计分析:使用Kolmogorov Smirnov检验对连续变量的正态性假设进行检验。使用Student's t独立检验比较两组的平均值。使用卡方检验/费舍尔精确检验比较了按类别划分的频率数据。计算风险比和95%置信度。 P <0.05被认为具有统计学意义。结果:子宫腺肌病的WOI被置换(非接受性ERA)为47.2%(17/36),而对照组为21.6%(73/338)(P <0.001,CI-8.7%-42.5%),从而使WOI置换的风险比增加。子宫腺肌病与对照的比率为2:1。子宫腺肌病的RIF发生率为66.6%,而对照组为34.9%(P <0.001,CI- 15.5%-47.9%)。子宫腺肌病组的个性化胚胎移植后的妊娠率为62.5%,这表明WOI移位是先前植入失败的子宫腺肌病患者植入失败的原因。结论:我们的研究表明,在子宫腺肌病患者胚胎移植前评估子宫内膜的接受性是谨慎的,以避免浪费好胚胎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号